Free Trial

Catherine Corrigan Sells 4,930 Shares of Exponent (NASDAQ:EXPO) Stock

Exponent logo with Business Services background

Key Points

  • CEO Catherine Corrigan sold 4,930 shares of Exponent stock at an average price of $66.82, totaling approximately $329,422.60, which decreased her ownership by 5.62%.
  • Exponent reported earnings of $0.52 per share for the last quarter, surpassing estimates, with revenue up 7.3% year-over-year to $132.87 million.
  • The company declared a quarterly dividend of $0.30, representing an annualized yield of 1.8%, with a current dividend payout ratio of 60.00%.
  • MarketBeat previews the top five stocks to own by November 1st.

Exponent, Inc. (NASDAQ:EXPO - Get Free Report) CEO Catherine Corrigan sold 4,930 shares of Exponent stock in a transaction dated Wednesday, October 15th. The shares were sold at an average price of $66.82, for a total value of $329,422.60. Following the completion of the sale, the chief executive officer directly owned 82,753 shares in the company, valued at approximately $5,529,555.46. This represents a 5.62% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Catherine Corrigan also recently made the following trade(s):

  • On Monday, September 15th, Catherine Corrigan sold 4,905 shares of Exponent stock. The shares were sold at an average price of $69.91, for a total value of $342,908.55.
  • On Thursday, August 14th, Catherine Corrigan sold 4,896 shares of Exponent stock. The shares were sold at an average price of $71.09, for a total value of $348,056.64.

Exponent Trading Up 1.5%

Shares of Exponent stock traded up $1.02 on Thursday, reaching $68.25. 546,500 shares of the company were exchanged, compared to its average volume of 343,539. The company has a market capitalization of $3.45 billion, a price-to-earnings ratio of 34.13 and a beta of 0.91. Exponent, Inc. has a one year low of $63.81 and a one year high of $114.99. The company has a 50-day moving average of $69.69 and a 200 day moving average of $73.99.

Exponent (NASDAQ:EXPO - Get Free Report) last released its earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.04. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The business had revenue of $132.87 million during the quarter, compared to analysts' expectations of $130.82 million. During the same period last year, the business earned $0.57 earnings per share. The firm's revenue was up 7.3% on a year-over-year basis. Analysts predict that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Friday, September 5th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend was Friday, September 5th. Exponent's dividend payout ratio is presently 60.00%.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. Brooklyn Investment Group boosted its position in shares of Exponent by 10,200.0% in the first quarter. Brooklyn Investment Group now owns 309 shares of the business services provider's stock valued at $25,000 after acquiring an additional 306 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new stake in Exponent in the 2nd quarter worth about $34,000. Bessemer Group Inc. boosted its holdings in Exponent by 103.3% in the 1st quarter. Bessemer Group Inc. now owns 681 shares of the business services provider's stock valued at $55,000 after purchasing an additional 346 shares during the period. SVB Wealth LLC acquired a new position in shares of Exponent during the 1st quarter worth approximately $80,000. Finally, Caitong International Asset Management Co. Ltd increased its holdings in shares of Exponent by 8,092.9% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,147 shares of the business services provider's stock worth $93,000 after purchasing an additional 1,133 shares during the period. Institutional investors own 92.37% of the company's stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a "hold (c-)" rating on shares of Exponent in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of "Hold".

Get Our Latest Report on Exponent

Exponent Company Profile

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Insider Buying and Selling by Quarter for Exponent (NASDAQ:EXPO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.